Rajendra Joshi

Dr. Rajendra Joshi


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
SGSmita Ghosh
Smita Ghosh
ABArchika C. Barve
Archika C. Barve
AKAnupa Kumbhar
Anupa Kumbhar
AKAvinash S. Kumbhar
Avinash S. Kumbhar
VPVedavati G. Puranik
Vedavati G. Puranik
RJRajendra Joshi
Rajendra Joshi

17 July 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SKShruti Koulgi
Shruti Koulgi
VJVinod Jani
Vinod Jani
MUMallikarjunachari Uppuladinne
Mallikarjunachari Uppuladinne
USUddhavesh Sonavane
Uddhavesh Sonavane
ANAsheet Kumar Nath
Asheet Kumar Nath
RJRajendra Joshi
Rajendra Joshi
The COVID-19 pandemic has been responsible for several deaths worldwide. The causative agent behind this disease is the Severe Acute Respiratory Syndrome – novel Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 belongs to the category of RNA viruses. The main protease, responsible for the cleavage of the viral polyprotein is considered as one of the hot targets for treating COVID-19. Earlier reports suggest the use of HIV anti-viral drugs for targeting the main protease of SARS-CoV, which caused SARS in the year 2002–2003. Hence, drug repurposing approach may prove to be useful in targeting the main protease of SARS-CoV-2. The high-resolution crystal structure of the main protease of SARS-CoV-2 (PDB ID: 6LU7) was used as the target. The Food and Drug Administration approved and SWEETLEAD database of drug molecules were screened. The apo form of the main protease was simulated for a cumulative of 150 ns and 10 μs open-source simulation data was used, to obtain conformations for ensemble docking. The representative structures for docking were selected using RMSD-based clustering and Markov State Modeling analysis. This ensemble docking approach for the main protease helped in exploring the conformational variation in the drug-binding site of the main protease leading to the efficient binding of more relevant drug molecules. The drugs obtained as top hits from the ensemble docking possessed anti-bacterial and anti-viral properties. This in silico ensemble docking approach would support the identification of potential candidates for repurposing against COVID-19. Communicated by Ramaswamy H. Sarma

17 July 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKShruti Koulgi
Shruti Koulgi
VJVinod Jani
Vinod Jani
MUMallikarjunachari V. N. Uppuladinne
Mallikarjunachari V. N. Uppuladinne
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi
The efforts towards developing a potential drug against the current global pandemic, COVID-19, have increased in the past few months. Drug development strategies to target the RNA dependent RNA polymerase (RdRP) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are being tried worldwide. The gene encoding this protein, is known to be conserved amongst positive strand RNA viruses. This enables an avenue to repurpose the drugs designed against earlier reported inhibitors of RdRP. One such strong inhibitor is remdesivir which has been used against EBOLA infections. The binding of remdesivir to RdRP of SARS-CoV-2 has been studied using the classical molecular dynamics and ensemble docking approach. A comparative study of the simulations of RdRP in the apo and remdesivir-bound form revealed blocking of the template entry site in the presence of remdesivir. The conformation changes leading to this event were captured through principal component analysis. The conformational and thermodynamic parameters supported the experimental information available on the involvement of crucial arginine, serine and aspartate residues belonging to the conserved motifs in RdRP functioning. The catalytic site comprising of SER 759, ASP 760, and ASP 761 (SDD) was observed to form strong contacts with remdesivir. The significantly strong interactions of these residues with remdesivir may infer the latter's binding similar to the normal nucleotides thereby remaining unidentified by the exonuclease activity of RdRP. The ensemble docking of remdesivir too, comprehended the involvement of similar residues in interaction with the inhibitor. This information on crucial interactions between conserved residues of RdRP with remdesivir through in silico approaches may be useful in designing inhibitors.

1 April 2010 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SSSmriti Sharma
Smriti Sharma
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi
Peptide Nucleic Acids (PNA) that bind sequence specifically to DNA/RNA are of major interest in the field of molecular biology and could form the basis for gene-targeted drugs. Molecular dynamics simulations are aimed to characterize the structural and dynamical features to understand the effect of backbone modification on the structure and dynamics along with the stability of the resulting 10mer complexes of PNA with DNA/RNA. Twelve Molecular Dynamics (MD) simulations of duplexes and triplexes with and without cyclohexyl modification were carried out for 10ns each. The simulations indicate that the cyclohexyl modification with different stereoisomers has influenced all the PNA-DNA/RNA complexes. Modification has added rigidity to backbone by restricting beta to +60 in case of (1R,2S) cyclohexyl PNA and to -60 in case of (1S,2R) cyclohexyl PNA. The results of MD simulations were able to show the backbone rigidification and preference for RNA complexes over DNA due to presence of cyclohexyl ring in the PNA backbone.

13 May 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SKShruti Koulgi
Shruti Koulgi
VJVinod Jani
Vinod Jani
MNMallikarjunachari Uppuladinne V. N.
Mallikarjunachari Uppuladinne V. N.
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi
Drug repurposing studies targeting inhibition of RNA dependent RNA polymerase (RdRP) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) have exhibited the potential effect of small molecules. In the present work a detailed interaction study between the phytochemicals from Indian medicinal plants and the RdRP of SARS-CoV-2 has been performed. The top four phytochemicals obtained through molecular docking were, swertiapuniside, cordifolide A, sitoindoside IX, and amarogentin belonging toSwertia chirayita,Tinospora cordifoliaandWithania somnifera. These ligands bound to the RdRP were further studied using molecular dynamics simulations. The principal component analysis of these systems showed significant conformational changes in the finger and thumb subdomain of the RdRP. Hydrogen bonding, salt-bridge and water mediated interactions supported by MM-GBSA free energy of binding revealed strong binding of cordifolide A and sitoindoside IX to RdRP. The ligand-interacting residues belonged to either of the seven conserved motifs of the RdRP. These residues were polar and charged amino acids, namely, ARG 553, ARG 555, ASP 618, ASP 760, ASP 761, GLU 811, and SER 814. The glycosidic moieties of the phytochemicals were observed to form favourable interactions with these residues. Hence, these phytochemicals may hold the potential to act as RdRP inhibitors owing to their stability in binding to the druggable site.

27 May 2014 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
VJVinod Jani
Vinod Jani
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi